中药结肠透析联合尿毒清颗粒对慢性肾脏病3～5期患者疗效及肾功能指标的影响

摘要
图/表
参考文献(27)
相关文章 (15)

全文: PDF (414 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨中药结肠透析联合尿毒清颗粒对慢性肾脏病3～5期患者疗效及肾功能指标的影响。方法选取2019年1月至2021年1月九江市第一人民医院收治的82例慢性肾脏病3～5期患者作为研究对象，采用随机数字表法将其分为常规组（41例）和研究组（41例）。常规组患者采用口服尿毒清颗粒治疗，研究组患者在常规组基础上采用中药结肠透析治疗。比较两组患者治疗前后的中医症状评分，治疗后的临床疗效，治疗前后的血尿酸（UA）、血肌酐（SCr）、血尿素氮（BUN）水平以及不良反应发生情况。结果治疗后，两组患者的主症评分、次症评分及总评分均低于治疗前，且研究组患者的主症评分、次症评分及总评分均低于常规组，差异有统计学意义（P＜0.05）。研究组患者的治疗总有效率高于常规组，差异有统计学意义（P＜0.05）。研究组患者的血UA、SCr、BUN水平低于常规组，差异有统计学意义（P＜0.05）。两组患者治疗期间的总不良反应发生率比较，差异无统计学意义（P＞0.05）。结论中药结肠透析联合尿毒清颗粒治疗慢性肾脏病3～5期患者，能够改善临床症状，提高疗效以及改善肾功能，且安全，具有一定的推广价值。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	晏慧民
	童薇
	邱国萍▲

关键词 ：中药结肠透析, 尿毒清颗粒, 血肌酐, 尿素氮

Abstract：Objective To investigate the curative effect of traditional Chinese medicine colon dialysis combined with Uremic Clearance Granules effect and on the renal function indexes in patients with stage 3-5 chronic kidney disease. Methods A total of 82 patients with stage 3-5 chronic kidney disease in the First People′s Hospital of Jiujiang City from January 2019 to January 2021 were selected as the objects, and they were divided into the routine group (41 cases) and the study group (41 cases) by random number table method. The routine group was treated with oral Uremic Clearance Granules, while the study group was treated with traditional Chinese medicine colon dialysis on the basis of the routine group. Chinese medicine symptom score before and after treatment, clinical efficacy after treatment, the levels of blood uric acid (UA), serum creatinine (SCr), blood urea nitrogen (BUN) before and after treatment, and occurrence of adverse reactions were compared between the two groups. Results After treatment, the main symptom score, secondary symptom score and total score of the two groups were lower than those before treatment, and the main symptom score, secondary symptom score and total score of the study group were lower than those of the routine group, the differences were statistically significant (P<0.05). The overall treatment efficiency rate of the study group was higher than that of the routine group, the difference was statistically significant (P<0.05). After treatment, the levels of blood UA, SCr, BUN in the two groups were lower than those before treatment, and the levels of blood UA, SCr, BUN in the study group were lower than those in the routine group, and the differences were statistically significant (P<0.05). There was no significant difference in the incidence of total adverse reactions during treatment between the two groups (P>0.05). Conclusion Traditional Chinese medicine colon dialysis combined with Uremic Clearance Granules in the treatment of patients with stage 3-5 chronic kidney disease can improve clinical symptoms, improve curative effect and improve renal function, which is safe and has certain popularization value.

Key words： Traditional Chinese medicine colon dialysis Uremic Clearance Granules Serum creatinine Urea nitrogen

基金资助:江西省中医药科研项目（2019A422）。

通讯作者: 邱国萍，女，主任医师，研究方向：血液净化学。

作者简介: 晏慧民，男，副主任医师，研究方向：慢性肾脏病的管理。

引用本文:

晏慧民；童薇；邱国萍▲. 中药结肠透析联合尿毒清颗粒对慢性肾脏病3～5期患者疗效及肾功能指标的影响[J]. 中国当代医药, 2022, 29(19): 105-108.
YAN Huimin； TONG Wei ； QIU Guoping▲. with Uremic Clearance Granules and its effect on renal function indexes in patients with stage 3-5 chronic kidney disease. 中国当代医药, 2022, 29(19): 105-108.

链接本文:

https://www.dangdaiyiyao.com/CN/ 或 https://www.dangdaiyiyao.com/CN/Y2022/V29/I19/105

[1]	Ojo AO，Held PJ，Port FK，et al.Chronic renal failure after transplantation of a nonrenal organ[J].N Engl J Med，2003， 349（10）：931-940.
[2]	Anderson CAM，Nguyen HA.Nutrition education in the care of patients with chronic kidney disease and end-stage renal disease[J].Semin Dial，2018，31（2）：115-121.
[3]	Gluba-Brzózka A，Franczyk B，Rysz J.Vegetarian diet in chronic kidney disease-a friend or foe[J].Nutrients，2017，9（4）：374.
[4]	Mikhail A，Brown C，Williams JA，et al.Renal association clinical practice guideline on anaemia of chronic kidney disease[J].BMC Nephrol，2017，18（1）：345.
[5]	Latcha S.Anemia management in cancer patients with chronic kidney disease[J].Semin Dial，2019，32（6）：513-519.
[6]	Garla V，Kanduri S，Yanes-Cardozo L，et al.Management of diabetes mellitus in chronic kidney disease[J].Minerva Endocrinol，2019，44（3）：273-287.
[7]	徐敏，李毅.结肠透析联合固本泄浊汤保留灌肠对慢性肾衰竭患者肾功能及氧化应激状态的影响[J].医学临床研究，2020，37（4）：619-621，627.
[8]	刘必成，伍敏.关于慢性肾脏病诊断标准的争议与思考[J].中华内科杂志，2009，48（12）：989-991.
[9]	郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002.
[10]	吴一帆，卢富华，傅立哲，等.慢性肾脏病患者中医证型分布与营养状态相关性分析[J].中国中西医结合肾病杂志，2012，13（1）：34-37.
[11]	王莉，李贵森，刘志红.中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J].肾脏病与透析肾移植杂志，2013，22（6）：554-559.
[12]	Hawley CE，Triantafylidis LK，Paik JM，et al.Opioid management in older adults with chronic kidney disease：a review[J].Am J Med，2019，132（12）：1386-1393.
[13]	Chowdhury R，Peel NM，Krosch M，et al.Frailty and chronic kidney disease：a systematic review[J].Arch Gerontol Geriatr，2017，68：135-142.
[14]	郑栓，万红波，郑建国，等.健脾补肾活血泄浊方联合杂合式血液净化疗法对慢性肾衰竭患者肾功能及血清CD4+/CD8+水平的影响[J].陕西中医，2019，40（2）：188-191.
[15]	Aursulesei V，Costache II.Anticoagulation in chronic kidney disease：from guidelines to clinical practice[J].Clin Cardiol，2019，42（8）：774-782.
[16]	王丽丽，何振生.补肾活血泄浊汤对2型糖尿病肾病肾功能衰竭患者肾功能及血清炎症因子的影响[J].中国中医急症，2019，28（6）：996-998.
[17]	郭建红，周岚，蒋春波，等.益肾清利、和络泄浊方联合中药灌肠治疗慢性肾脏病4期45例临床研究[J].江苏中医药，2019，51（10）：39-41.
[18]	Mallamaci F，Pisano A，Tripepi G，et al.Physical activity in chronic kidney disease and the EXerCise Introduction to Enhance trial[J].Nephrol Dial Transplant，2020，35（Suppl 2）：ii18-ii22.
[19]	Zhang R，Wang S，Zhang M，et al.Hyponatremia in patients with chronic kidney disease[J].Hemodial Int，2017，21（1）：3-10.
[20]	Carrero JJ，Hecking M，Chesnaye NC，et al.Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease[J].Nat Rev Nephrol，2018，14（3）：151-164.
[21]	Vassalotti JA，Centor R，Turner BJ，et al.Practical approach to detection and management of chronic kidney disease for the primary care clinician[J].Am J Med，2016，129（2）：153.e7-162.e7.
[22]	Drew DA，Weiner DE，Sarnak MJ.Cognitive impairment in CKD：pathophysiology，management，and prevention[J].Am J Kidney Dis，2019，74（6）：782-790.
[23]	Romero-González G，Ravassa S，González O，et al.Burden and challenges of heart failure in patients with chronic kidney disease.A call to action[J].Nefrologia（Engl Ed），2020， 40（3）：223-236.
[24]	Floege J.Phosphate binders in chronic kidney disease：an updated narrative review of recent data[J].J Nephrol，2020， 33（3）：497-508.
[25]	Vilay AM.Antibiotic dosing in chronic kidney disease and end-stage renal disease：a focus on contemporary challenges[J].Adv Chronic Kidney Dis，2019，26（1）：61-71.
[26]	王湘川，刘春慧，吴灿.结肠透析配合尿毒清颗粒保留灌肠治疗慢性肾功能衰竭的疗效[J].实用医学杂志，2012， 28（15）：2528-2530.
[27]	Wang Z，Zhang S，Zheng X，et al.Efficacy and safety of colonic dialysis combined with traditional Chinese medicine retention enema in the treatment of chronic renal failure：a protocol for systematic review and meta-analysis[J].Medicine （Baltimore），2021，100（50）：e28082.